Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crosstalk between dendritic cells and T lymphocytes during atherogenesis: Focus on antigen presentation and break of tolerance
Rossella Bellini, Fabrizia Bonacina, Giuseppe Danilo Norata
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 13

Showing 13 citing articles:

Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Evgeni Gusev, Alexey Sarapultsev
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7910-7910
Open Access | Times Cited: 109
Autoimmune diseases and atherosclerotic cardiovascular disease
Florentina Porsch, Christoph J. Binder
Nature Reviews Cardiology (2024) Vol. 21, Iss. 11, pp. 780-807
Closed Access | Times Cited: 26
Revisiting regulatory T cells as modulators of innate immune response and inflammatory diseases
Qifeng Ou, Rachael Power, Matthew D. Griffin
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors
Antonio Gallo, Wilfried Le Goff, Raul D. Santos, et al.
European Journal of Clinical Investigation (2024)
Open Access | Times Cited: 6
Exosome-mediated communication between T cells and dendritic cells: Implications for therapeutic strategies
Tahereh Kashkoulinejad Kouhi
Cytokine (2025) Vol. 189, pp. 156914-156914
Closed Access
Exploiting regulatory T cells (Tregs): Cutting-edge therapy for autoimmune diseases
Marwa Hassan, Mohamed Elzallat, Dina Mostafa Mohammed, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114624-114624
Open Access
Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis
Jinpeng Jing, Jing Guo, Rui Dai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Oxidized Low-Density Lipoprotein and Its Role in Immunometabolism
Negin Mosalmanzadeh, Brandt D. Pence
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11386-11386
Open Access | Times Cited: 3
Cells in Atherosclerosis: Focus on Cellular Senescence from Basic Science to Clinical Practice
Andrea Molnár, Dorottya Pásztor, Zsófia Tarcza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17129-17129
Open Access | Times Cited: 7
Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling
Hongji Zhou, Rui Zhang, Min Li, et al.
Journal of Immunology Research (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 2
Targeting anticancer immunity in melanoma tumor microenvironment: Unleashing the potential of adjuvants, drugs, and phytochemicals
Jingping Wang, Yaping Wang, Xiaofang Jiang
Journal of drug targeting (2024) Vol. 32, Iss. 9, pp. 1052-1072
Closed Access | Times Cited: 2
Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progression
Rossella Bellini, Annalisa Moregola, Jasmine Nour, et al.
Atherosclerosis Plus (2022) Vol. 51, pp. 8-12
Open Access | Times Cited: 4
Autoantibodies to Oxidatively Modified Peptide: Potential Clinical Application in Coronary Artery Disease
I-Jung Tsai, Wen‐Chi Shen, Jiazhen Wu, et al.
Diagnostics (2022) Vol. 12, Iss. 10, pp. 2269-2269
Open Access | Times Cited: 1
Page 1

Scroll to top